Literature DB >> 31609872

Implementation of a Shared Medical Appointment as a Holistic Approach to CHF Management.

Teresa Law1, Stacey Jones, Shellye Vardaman.   

Abstract

Congestive heart failure is a costly chronic disease within the United States. The purpose of this study was to examine the effect of a holistic shared medical appointment (SMA) approach to congestive heart failure. Findings suggest the SMA approach improves depression, quality of life (QOL), and health-promoting behaviors. This study implemented congestive heart failure self-management education in primary care using a holistic multidisciplinary approach with SMA to provide evidence-based interventions to improve depression, QOL, and health promotion outcomes. Patients participating in the holistic multidisciplinary SMA experienced improvement in depression, QOL, and health promotion behaviors. A comparison of the means between preintervention and postintervention showed an overall reduction in systolic blood pressure, weight, depression scores, QOL scores, and several indicators of health promotion lifestyle.

Entities:  

Mesh:

Year:  2019        PMID: 31609872     DOI: 10.1097/HNP.0000000000000353

Source DB:  PubMed          Journal:  Holist Nurs Pract        ISSN: 0887-9311            Impact factor:   1.000


  2 in total

1.  The influence of integrated healthcare on the nursing effect, negative emotions, and heart failure indicators in acute heart failure patients.

Authors:  Haiyang Guan; Li Wang; Baofeng Zhu; Ying Liu; Jianhong Ji
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  "Living Well with Chronic Pain": Integrative Pain Management via Shared Medical Appointments.

Authors:  Josie Znidarsic; Kellie N Kirksey; Stephen M Dombrowski; Anne Tang; Rocio Lopez; Heather Blonsky; Irina Todorov; Dana Schneeberger; Jonathan Doyle; Linda Libertini; Starkey Jamie; Tracy Segall; Andrew Bang; Kathy Barringer; Bar Judi; Jane Pernotto Ehrman; Michael F Roizen; Mladen Golubić
Journal:  Pain Med       Date:  2021-02-04       Impact factor: 3.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.